Drug Target Review

APRIL 9, 2024

In 2005, he joined CNIO to lead the Genomic Instability Group where he has been ever since. Initial works from the lab concentrated on exploring the role of replicative stress in cancer and ageing, for which the group combined cell biology, mouse models and drug development projects.

RNA 64

RNA Cell Biology Clinical Development DNA 64

Codon

APRIL 9, 2024

It was only in 2005, after the emergence of widespread resistance of P. It was only in 2005, after the emergence of widespread resistance of P. With help from the Global Fund to Fight AIDS, Tuberculosis, and Malaria (GFATM), artemisinin-based combination therapy became much more economically accessible worldwide.

Drugs 126

Drugs Science Research Doctors 126

DrugBank

JUNE 27, 2023

Their use, as well as their integration into other types of data, has enabled the development of more precise therapies. Conclusion Since the first GWAS was published in 2005, there have been more than 50,000 significant variant-trait associations identified. 53 , 1527–1533 (2021).  Barrio-Hernandez, I.

Disease 88

Disease Treatment Drugs Clinical Trials 88

Codon

AUGUST 10, 2023

” Foundations Basics of Synthetic Biology →Foundations for engineering biology , by Endy D. Nature (2005). Link →A brief history of synthetic biology , by Cameron D.E. Link Synthetic biology: applications come of age , by Khalil A.S. & Nature Reviews Molecular Cell Biology (2009).

DNA 90

DNA Cell Biology Molecular Biology Engineering 90

Codon

AUGUST 10, 2023

” Foundations Basics of Synthetic Biology →Foundations for engineering biology , by Endy D. Nature (2005). Link →A brief history of synthetic biology , by Cameron D.E. Link Synthetic biology: applications come of age , by Khalil A.S. & Nature Reviews Molecular Cell Biology (2009).

DNA 52

DNA Cell Biology Engineering Molecular Biology 52